Synexus Announces U.K. Partnership with Firstsource
Because identifying and communicating with patients who are willing to participate in trials can be a significant challenge, Synexus says it is keen to adopt a streamlined process that offers consistency across multiple channels.
Synexus, a site management organization headquartered in Manchester, UK, has appointed business process management company Firstsource Solutions to review and support its strategy for communicating with patients across the United Kingdom. The aim is to create real-time responsiveness and dialogue, leading to an enhanced patient experience throughout the clinical trial process, according to the company.
Because identifying and communicating with patients who are willing to participate in trials can be a significant challenge, Synexus says it is keen to adopt a streamlined process that offers consistency across multiple channels and builds awareness and understanding of the benefits that clinical research can bring for patients, leading to better engagement.
“We selected Firstsource as our partner of choice because of the significant experience they have with major consumer brands that are highly sophisticated when it comes to adopting a multi-channel approach,” noted Sarah Beeby, VP Global Strategic Service Development at Synexus. “We hope to learn from their experiences and apply these to develop a communications strategy that will boost the awareness of clinical trials.”
Targeted messaging of engaging content across various platforms will boost understanding of the benefits of clinical trial participation, and these benefits will carry through the life of the trial by ensuring participants feel well informed and stay motivated to the end of the study, she added.
“In today’s multi-channel world, multiple touch points are becoming a business necessity rather than a ‘nice to have’, and the health sector is no exception,” said Gavin Snell, President, Customer Management, Firstsource Solutions. “Whilst Synexus has offered numerous engagement opportunities to its patients this project will take the business to the next level and really transform the patient experience.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
